Search Results - cong+tang

1 Results Sort By:
Targeted Immunotherapy for KRAS-Driven Cancers
Application Targeted immunotherapy and companion biosensing approach for cancers harboring the KRASG12V mutation. Key Benefits First-in-class therapeutic strategy specifically designed for KRASG12V-positive cancers. Addresses a significant unmet need in oncology where no approved KRASG12V-targeted therapies currently exist. Restores the body’s...
Published: 2/23/2026   |   Inventor(s): Haian Fu, Cong Tang, Xiulei Mo
Keywords(s): Drug Target Identification, Enzyme and Protein Research, Immunology and Inflammation Treatments, Oncology Treatments
Category(s): TechPub Algolia > Drug Discovery, TechPub Algolia > Therapeutics